Cytokine Combination Therapy With Long-Acting Erythropoietin and Granulocyte Colony Stimulating Factor Improves Cardiac Function But is Not Superior Than Monotherapy in a Mouse Model of Acute Myocardial Infarction (Q46610002)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 4, 2010

Language	Label	Description	Also known as
English	Cytokine Combination Therapy With Long-Acting Erythropoietin and Granulocyte Colony Stimulating Factor Improves Cardiac Function But is Not Superior Than Monotherapy in a Mouse Model of Acute Myocardial Infarction	scientific article published on May 4, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Cytokine Combination Therapy With Long-Acting Erythropoietin and Granulocyte Colony Stimulating Factor Improves Cardiac Function But is Not Superior Than Monotherapy in a Mouse Model of Acute Myocardial Infarction (English)

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

animal disease model

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670846

13 June 2024

10

object named as

Andrew Boyle

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670846

13 June 2024

author name string

Yerem Yeghiazarians

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Muhammad Khan

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Yan Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Sarah Jahn

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Megha Prasad

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Rachel Mirsky

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Henry Shih

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Petros Minasi

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

William Grossman

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Franca S. Angeli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670846

13 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20670846

13 June 2024

publication date

4 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

full work available at URL

https://api.elsevier.com/content/article/PII:S1071916410001181?httpAccept=text/xml

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

https://api.elsevier.com/content/article/PII:S1071916410001181?httpAccept=text/plain

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Journal of Cardiac Failure

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

16

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

669-678

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

1

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin improves cardiac contractility in post-hypoxic mice

2

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes

3

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

4

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

5

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment

6

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction

7

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine

8

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Effect of a long-term treatment with a low-dose granulocyte colony-stimulating factor on post-infarction process in the heart.

9

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury

10

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

11

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction

12

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells

13

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

14

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

16

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

17

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization

18

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography

21

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction

22

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit

23

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

24

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart

25

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Effects of erythropoietin on cardiac remodeling after myocardial infarction.

26

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

A novel protective effect of erythropoietin in the infarcted heart

27

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Percutaneous endocardial injection of erythropoietin: assessment of cardioprotection by electromechanical mapping

28

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

29

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.

31

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

32

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Erythropoietin and VEGF exhibit equal angiogenic potential

33

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion

34

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.

36

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy

37

1 reference

10.1016/J.CARDFAIL.2010.03.008

https://api.crossref.org/works/10.1016/J.CARDFAIL.2010.03.008

13 June 2024

Identifiers

10.1016/J.CARDFAIL.2010.03.008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/20670846

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46610002&oldid=2178216896"